Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,847.30",
    "chg": 12.9,
    "chgp": "0.7%",
    "dir": 1,
    "prev_price": "1,834.40",
    "mcapval": "440,818.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "28.9 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "P/E at 36.19 vs Industry's 34.54: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strong-buy-rating-reinforces-its-nifty-50-significance-3981028",
        "imagepath": "",
        "date": "2026-05-08 09:21:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Capitalisation Impact</strong></p>\n                <p>As a prominent member of the Nifty 50, Sun Pharmaceutical Industries Ltd holds considerable influence on the index’s overall performance. With a market capitalisation of ₹4,40,038.03 crores, it ranks among the largest companies in the Pharmaceuticals & Biotechnology sector, a segment that has demonstrated resilience amid volatile market conditions. The company’s inclusion in the Nifty 50 not only reflects its scale and liquidity but also ensures significant institutional participation, as many mutual funds and ETFs track this benchmark closely.</p>\n                <p>The stock’s current valuation metrics reveal a price-to-earnings (P/E) ratio of 36.19, slightly above the industry average of 34.54..."
      },
      {
        "title": "P/E at 36.57 vs Industry's 34.48: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strong-buy-momentum-amidst-nifty-50-benchmark-significance-3979161",
        "imagepath": "",
        "date": "2026-05-07 09:21:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Norms</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> trades at a P/E of 36.57, slightly above the Pharmaceuticals & Biotechnology industry average of 34.48. This premium, approximately 6.0%, suggests that investors are willing to pay more for the stock relative to its peers, reflecting expectations of either superior earnings growth or a perception of higher quality. However, this valuation is not excessively stretched compared to some high-growth peers in the sector. The market capitalisation of Rs 4,43,973 crore firmly places the company in the large-cap category, underscoring its established presence in the industry.</p>..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1843.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-marking-significant-milestone-3977804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_priceRelatedfactors_3977804.png",
        "date": "2026-05-06 11:05:27",
        "description": "With a close approach to its 52-week high at Rs 1843.95 on 6 Jun 2026, Sun Pharmaceutical Industries Ltd has demonstrated notable price momentum, supported by a broad alignment of technical indicators across weekly and monthly timeframes."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-upgraded-to-strong-buy-on-robust-fundamentals-and-technicals-3977159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_mojoScore_3977159.png",
        "date": "2026-05-06 08:31:48",
        "description": "Sun Pharmaceutical Industries Ltd has been upgraded from a Buy to a Strong Buy rating, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, announced on 5 May 2026, underscores the company’s solid fundamentals, bullish technical momentum, and favourable market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-technical-momentum-shifts-signal-bullish-outlook-3976926",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_technicaldot_3976926.png",
        "date": "2026-05-06 08:05:08",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. Despite a minor day decline of 0.18%, the stock’s underlying technical parameters and long-term returns suggest a robust outlook for investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "P/E at 36.04 vs Industry's 33.77: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-3975401",
        "imagepath": "",
        "date": "2026-05-05 09:20:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Sun Pharmaceutical Industries Ltd holds a pivotal role in representing the Pharmaceuticals & Biotechnology sector within India’s premier benchmark index. This membership not only enhances the stock’s visibility among domestic and global investors but also ensures its inclusion in numerous index-tracking funds and ETFs, thereby supporting liquidity and demand. The company’s market capitalisation of approximately ₹4,36,463 crore firmly places it in the large-cap category, reinforcing its stature as a blue-chip stock.</p>\n                <p>Being part of the Nifty 50 also subjects Sun Pharma to rigorous scrutiny and performance expectations, as the index is often viewed as a baro..."
      },
      {
        "title": "P/E at 35.73 vs Industry's 33.40: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-amid-nifty-50-membership-and-institutional-interest-3973323",
        "imagepath": "",
        "date": "2026-05-04 10:30:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Norms</strong></p>\n                <p>The current P/E of 35.73 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands approximately 7% above the Pharmaceuticals & Biotechnology industry average of 33.40. This premium suggests that investors are willing to pay slightly more for the stock relative to its peers, reflecting expectations of either superior earnings growth or a perception of higher quality. However, this premium is not excessive when compared to historical valuation spreads within the sector, which have occasionally seen wider divergences.</p>\n                <p>Such a valuation premium often implies confidence in the company’s earnings stab..."
      },
      {
        "title": "Sun Pharmaceutical Gains 11.62%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-gains-1162-5-key-factors-driving-the-weeks-rally-3971569",
        "imagepath": "",
        "date": "2026-05-02 14:02:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Intraday high surge to Rs.1,728.10 with strong volume and call option activity</p>\n                    <p><strong>28 Apr:</strong> Upgrade to Buy by MarketsMOJO; robust institutional delivery volumes</p>\n                    <p><strong>29 Apr:</strong> Continued steady gains with strong institutional participation</p>\n                    <p><strong>30 Apr:</strong> Surge in call option activity at Rs.1,800 strike ahead of May expiry</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,619.95</div></div>\n                    <div class=\"stat-i..."
      },
      {
        "title": "11,697 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Climbs 1.52%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-amid-bullish-momentum-3970355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SunPharmaceutic_most_active_stocks_calls_3970355.png",
        "date": "2026-04-30 15:00:07",
        "description": "On 30 Apr 2026, 11,697 call contracts on Sun Pharmaceutical Industries Ltd exchanged hands at the Rs 1,800 strike price, closely aligned with the stock’s closing price of Rs 1,800.30. This synchrony between the options and cash markets highlights a focused directional stance as the stock continues its four-day rally, gaining 1.52% on the day."
      }
    ],
    "total": 1093,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-May-2026",
      "details": "Transcript: Sun Pharma - Organon Acquisition Investor Call",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "27-Apr-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "27-Apr-2026",
      "details": "Investor Presentation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

P/E at 36.19 vs Industry's 34.54: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-08 09:21:22

Index Membership and Market Capitalisation Impact

As a prominent member of the Nifty 50, Sun Pharmaceutical Industries Ltd holds considerable influence on the index’s overall performance. With a market capitalisation of ₹4,40,038.03 crores, it ranks among the largest companies in the Pharmaceuticals & Biotechnology sector, a segment that has demonstrated resilience amid volatile market conditions. The company’s inclusion in the Nifty 50 not only reflects its scale and liquidity but also ensures significant institutional participation, as many mutual funds and ETFs track this benchmark closely.

The stock’s current valuation metrics reveal a price-to-earnings (P/E) ratio of 36.19, slightly above the industry average of 34.54...

Read full news article

P/E at 36.57 vs Industry's 34.48: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-07 09:21:09

Valuation Picture: Premium Amidst Sector Norms

Sun Pharmaceutical Industries Ltd trades at a P/E of 36.57, slightly above the Pharmaceuticals & Biotechnology industry average of 34.48. This premium, approximately 6.0%, suggests that investors are willing to pay more for the stock relative to its peers, reflecting expectations of either superior earnings growth or a perception of higher quality. However, this valuation is not excessively stretched compared to some high-growth peers in the sector. The market capitalisation of Rs 4,43,973 crore firmly places the company in the large-cap category, underscoring its established presence in the industry.

...

Read full news article

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1843.95

2026-05-06 11:05:27

With a close approach to its 52-week high at Rs 1843.95 on 6 Jun 2026, Sun Pharmaceutical Industries Ltd has demonstrated notable price momentum, supported by a broad alignment of technical indicators across weekly and monthly timeframes.

Read full news article

Sun Pharmaceutical Industries Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals

2026-05-06 08:31:48

Sun Pharmaceutical Industries Ltd has been upgraded from a Buy to a Strong Buy rating, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, announced on 5 May 2026, underscores the company’s solid fundamentals, bullish technical momentum, and favourable market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-06 08:05:08

Sun Pharmaceutical Industries Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. Despite a minor day decline of 0.18%, the stock’s underlying technical parameters and long-term returns suggest a robust outlook for investors in the pharmaceuticals and biotechnology sector.

Read full news article

P/E at 36.04 vs Industry's 33.77: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-05 09:20:56

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Sun Pharmaceutical Industries Ltd holds a pivotal role in representing the Pharmaceuticals & Biotechnology sector within India’s premier benchmark index. This membership not only enhances the stock’s visibility among domestic and global investors but also ensures its inclusion in numerous index-tracking funds and ETFs, thereby supporting liquidity and demand. The company’s market capitalisation of approximately ₹4,36,463 crore firmly places it in the large-cap category, reinforcing its stature as a blue-chip stock.

Being part of the Nifty 50 also subjects Sun Pharma to rigorous scrutiny and performance expectations, as the index is often viewed as a baro...

Read full news article

P/E at 35.73 vs Industry's 33.40: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-04 10:30:45

Valuation Picture: Premium Amidst Sector Norms

The current P/E of 35.73 for Sun Pharmaceutical Industries Ltd stands approximately 7% above the Pharmaceuticals & Biotechnology industry average of 33.40. This premium suggests that investors are willing to pay slightly more for the stock relative to its peers, reflecting expectations of either superior earnings growth or a perception of higher quality. However, this premium is not excessive when compared to historical valuation spreads within the sector, which have occasionally seen wider divergences.

Such a valuation premium often implies confidence in the company’s earnings stab...

Read full news article

Sun Pharmaceutical Gains 11.62%: 5 Key Factors Driving the Week’s Rally

2026-05-02 14:02:36

Key Events This Week

27 Apr: Intraday high surge to Rs.1,728.10 with strong volume and call option activity

28 Apr: Upgrade to Buy by MarketsMOJO; robust institutional delivery volumes

29 Apr: Continued steady gains with strong institutional participation

30 Apr: Surge in call option activity at Rs.1,800 strike ahead of May expiry

Week Open

Rs.1,619.95

Read full news article

11,697 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Climbs 1.52%

2026-04-30 15:00:07

On 30 Apr 2026, 11,697 call contracts on Sun Pharmaceutical Industries Ltd exchanged hands at the Rs 1,800 strike price, closely aligned with the stock’s closing price of Rs 1,800.30. This synchrony between the options and cash markets highlights a focused directional stance as the stock continues its four-day rally, gaining 1.52% on the day.

Read full news article

View All News